McCarthy W, Huq S, Allen K, Scally L, Petri A, Wujek M
Front Behav Neurosci. 2022; 16:958342.
PMID: 36204485
PMC: 9530781.
DOI: 10.3389/fnbeh.2022.958342.
Marrero M, Field S, Skibiel A, Dado-Senn B, Driver J, Laporta J
Sci Rep. 2020; 10(1):9712.
PMID: 32546841
PMC: 7297988.
DOI: 10.1038/s41598-020-66326-w.
Satala G, Duszynska B, Lenda T, Nowak G, Bojarski A
Mol Neurobiol. 2017; 55(4):2897-2910.
PMID: 28455702
PMC: 5842505.
DOI: 10.1007/s12035-017-0536-0.
Selvamani A, Lincoln C, Uphouse L
Behav Brain Res. 2007; 179(1):99-106.
PMID: 17336403
PMC: 1950743.
DOI: 10.1016/j.bbr.2007.01.015.
Pucadyil T, Kalipatnapu S, Chattopadhyay A
Cell Mol Neurobiol. 2005; 25(3-4):553-80.
PMID: 16075379
PMC: 11529526.
DOI: 10.1007/s10571-005-3969-3.
The recombinant 5-HT1A receptor: G protein coupling and signalling pathways.
Raymond J, Mukhin Y, Gettys T, Garnovskaya M
Br J Pharmacol. 1999; 127(8):1751-64.
PMID: 10482904
PMC: 1566169.
DOI: 10.1038/sj.bjp.0702723.
Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons.
Bockaert J, Dumuis A, Bouhelal R, Sebben M, Cory R
Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(5):588-92.
PMID: 2886925
DOI: 10.1007/BF00169129.
Central serotonin receptors: effector systems, physiological roles and regulation.
Conn P, Sanders-Bush E
Psychopharmacology (Berl). 1987; 92(3):267-77.
PMID: 2819915
DOI: 10.1007/BF00210830.
The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.
Dumuis A, Sebben M, Bockaert J
Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(4):403-10.
PMID: 2555720
DOI: 10.1007/BF00167041.
Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava.
Sumner M, Feniuk W, Humphrey P
Br J Pharmacol. 1989; 97(1):292-300.
PMID: 2541857
PMC: 1854479.
DOI: 10.1111/j.1476-5381.1989.tb11953.x.
The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors.
Julius D, Huang K, Livelli T, Axel R, Jessell T
Proc Natl Acad Sci U S A. 1990; 87(3):928-32.
PMID: 2300586
PMC: 53382.
DOI: 10.1073/pnas.87.3.928.
Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
Backus L, Sharp T, Grahame-Smith D
Br J Pharmacol. 1990; 100(4):793-9.
PMID: 2145051
PMC: 1917590.
DOI: 10.1111/j.1476-5381.1990.tb14094.x.
The 5-HT1A receptor: an overview of recent advances.
El Mestikawy S, Fargin A, Raymond J, Gozlan H, Hnatowich M
Neurochem Res. 1991; 16(1):1-10.
PMID: 2052135
DOI: 10.1007/BF00965820.
Functional expression of human 5-HT1A receptors and differential coupling to second messengers in CHO cells.
Raymond J, Albers F, Middleton J
Naunyn Schmiedebergs Arch Pharmacol. 1992; 346(2):127-37.
PMID: 1448178
DOI: 10.1007/BF00165293.
Serotonin regulates the phase of the rat suprachiasmatic circadian pacemaker in vitro only during the subjective day.
Medanic M, Gillette M
J Physiol. 1992; 450:629-42.
PMID: 1432721
PMC: 1176142.
DOI: 10.1113/jphysiol.1992.sp019147.
Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis.
Varrault A, Bockaert J, Waeber C
Mol Biol Cell. 1992; 3(9):961-9.
PMID: 1330092
PMC: 275657.
DOI: 10.1091/mbc.3.9.961.
